Feb 3, 2015, 10:40
by
Michael Croft
February 3, 2015 | The latest news and product releases for clinical IT and trial management:
Cypher Genomics and Sequenom
announced a development agreement for next generation noninvasive prenatal
tests (NIPT). Sequenom will use Cypher's genome interpretation technology,
Mantis, to advance its analysis of clinically relevant fetal sub-chromosomal
variants detected in maternal blood. Sub-chromosomal variants represent
more than half of rare chromosomal abnormalities, and are more difficult
to detect than the aneuploidies commonly covered by NIPT. Press
release
Oracle introduced Oracle Health Sciences InForm Medication Adherence Insights Cloud
Service to track and manage the use of
medication during clinical trials. This solution, developed in partnership with
Proteus Digital Health, automates data collection and integrates adherence data into an electronic data capture
system. It eliminates manual processes for collecting adherence data, such as
pill counts and patient questionnaires. Press release
Novella
Clinical, a Quintiles company, and
the Cardiovascular Research Foundation (CRF) announced a preferred provider collaboration to offer
clinical trial services to developers of cardiovascular drugs and devices, from
preclinical to post-market studies. Novella and CRF will offer sponsors access to leading
interventional cardiologists, CRFiCOR, the Clinical Trials Center’s cardiovascular
imaging laboratories, and Novella’s clinical trial operations services. The service
will include protocol development, trial design, statistical analysis, clinical
monitoring, and data management. Press
release
goBalto received $12 million in funding from Mitsui Global Investment and
Dolby Family Ventures. goBalto will direct the new funding toward continued
growth and new software development. The funding round follows a year in which
the number of studies started in Activate, goBalto’s flagship study startup
platform, tripled. Press release
3Scan closed a
Series A fundraising round of $6.7 million. The financing, led by Lux Capital,
will support the continued development of 3Scan’s Knife Edge Scanning
Microscope (KESM) technology. KESM automatically sections and images tissue
samples to create high-resolution outputs, up to a terabyte per cubic
centimeter, which are used to render 3D tissue reconstruction models in an
interactive format. KESM can be used to perform quantified image analysis of
tissues as thin as a submicron. Press
release
MedNet Solutions announced the latest release of iMedNet
eClinical, a cloud-based clinical study management platform. Press
release
ABD Insurance and Financial Services (ABD)
announced the addition of new insurance and technology offerings in their Life
Science Practice: a Client Portal and Clinical Trial Pac coverage. The Client
Portal creates a single source of information across all lines of business in a
secure, cloud-based platform, and includes the Clinical Trial Insurance
Platform, where clients can review country-specific insurance requirements by
clicking on an interactive country map by region. Press
release